Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Related Research units
Abstract
Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-? (IFN-?). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 2 |
| ISSN | 0003-4819 |
| Publication status | Published - 2012 |
| pubmed | 22801672 |
|---|
